BioAtla

IPO

San Diego, United States · Founded 2007 · $112.5M raised

Founded
2007
Business Model
B2B
Total Funding
$112.5M
Last Round
$40.0M Corporate RoundDec 2025
Rounds
2

About

BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using its proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!) platforms. These technologies, protected by more than 700 issued patents and patent applications, allow the company to develop novel biologics that are safer and more effective by more selectively targeting cancer tissue and improving manufacturability. Improved selectivity for the tumor microenvironment expands the universe of potential drug targets, enabling treatment of previously untreatable cancers.

Summary

BioAtla is a Biotech company based in San Diego, United States, founded in 2007. It has raised $112.5M in total across 2 rounds, most recently a $40.0M Corporate Round round in Dec 2025. Investors include Soleus Capital, HBM Healthcare Investments and Cormorant Asset Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundDec 2025
$40.0M

Sign up to see all 3 rounds

Series D through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioAtla on Indexed.vc
<a href="https://indexed.vc/companies/bioatla"><img src="https://indexed.vc/api/badge/company/bioatla" alt="BioAtla on Indexed.vc" width="260" height="76" /></a>